Mangoceuticals, Inc. (MGRX)
MGRX moved a median of -0.66% 30 minutes after news, and -1.21% by the close. How MGRX actually reacts to news — the realized, point-in-time move the market made, measured across 221 labeled events over the last three years with zero look-ahead.
MGRX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 44% | 213 |
| 30-min | -0.66% | 41% | 219 |
| 60-min | -0.88% | 39% | 221 |
| to close | -1.21% | 43% | 219 |
| Middle 50% of MGRX reactions | -4.76% to +1.73% |
|---|---|
| Median reaction (30-min) | -0.66% |
| Measured reactions | 221 |
Half of all Mangoceuticals, Inc. news events land between -4.76% and +1.73% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when MGRX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to MGRX's baseline. Nothing else.
Recent MGRX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K MANGOCEUTICALS, INC. For: Oct 08 | SEC filing · Form 8-K | SEC EDGAR | — | -8.63% | |
| Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close | Press release | GlobeNewswire | — | -8.63% | |
| Form 8-K MANGOCEUTICALS, INC. For: Sep 30 | SEC filing · Form 8-K | SEC EDGAR | +0.18% | -3.26% | |
| Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche | Press release | GlobeNewswire | +1.43% | -0.66% | |
| Form 8-K MANGOCEUTICALS, INC. For: Aug 19 | SEC filing · Form 8-K | SEC EDGAR | +2.28% | +3.82% | |
| MGRX Stock Alert: Halper Sadeh LLC is Investigating Whether Mangoceuticals, Inc. is Obtaining a Fair Price for its Shareholders | Press release | Business Wire | +2.41% | +7.89% | |
| Form 10-Q MANGOCEUTICALS, INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.45% | -8.56% | |
| Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets | Press release | GlobeNewswire | +0.45% | -8.56% | |
| Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure | Press release | GlobeNewswire | -0.60% | -10.98% | |
| Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development | Press release | GlobeNewswire | -0.60% | -10.98% | |
| Form 8-K MANGOCEUTICALS, INC. For: Aug 04 | SEC filing · Form 8-K | SEC EDGAR | -0.24% | +2.78% | |
| Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination | Press release | GlobeNewswire | -0.24% | +2.78% | |
| Form 8-K MANGOCEUTICALS, INC. For: Jul 28 | SEC filing · Form 8-K | SEC EDGAR | -4.48% | -30.09% | |
| Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology | Press release | GlobeNewswire | -4.48% | -30.09% | |
| Form S-8 MANGOCEUTICALS, INC. | SEC filing · Form S-8 | SEC EDGAR | +0.00% | -1.31% | |
| Form 8-K MANGOCEUTICALS, INC. For: Jun 29 | SEC filing · Form 8-K | SEC EDGAR | +1.67% | -0.84% | |
| Form 10-Q MANGOCEUTICALS, INC. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -2.12% | +4.15% | |
| Form NT 10-Q MANGOCEUTICALS, INC. For: Mar 31 | SEC filing · Form NT | SEC EDGAR | +0.95% | -3.80% | |
| Form 10-K MANGOCEUTICALS, INC. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +2.08% | +0.00% | |
| Form NT 10-K MANGOCEUTICALS, INC. For: Dec 31 | SEC filing · Form NT | SEC EDGAR | +2.08% | +0.00% | |
| Form 8-K MANGOCEUTICALS, INC. For: Mar 16 | SEC filing · Form 8-K | SEC EDGAR | +1.03% | +0.54% | |
| Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. | Press release | GlobeNewswire | +1.03% | +0.54% | |
| Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds | Press release | GlobeNewswire | -4.20% | -13.73% | |
| Form 8-K MANGOCEUTICALS, INC. For: Feb 23 | SEC filing · Form 8-K | SEC EDGAR | +5.07% | +10.21% | |
| Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study | Press release | GlobeNewswire | +5.07% | +10.21% | |
| Form 8-K MANGOCEUTICALS, INC. For: Feb 19 | SEC filing · Form 8-K | SEC EDGAR | -4.73% | -14.79% | |
| MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program | Press release | GlobeNewswire | -4.73% | -14.79% | |
| Form 8-K MANGOCEUTICALS, INC. For: Feb 04 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.18% | |
| Form EFFECT MANGOCEUTICALS, INC. | SEC filing · Form EFFECT | SEC EDGAR | -1.76% | -14.11% | |
| Form S-1/A MANGOCEUTICALS, INC. | SEC filing · Form S-1 | SEC EDGAR | +0.00% | -12.83% | |
| Form S-1 MANGOCEUTICALS, INC. | SEC filing · Form S-1 | SEC EDGAR | +0.01% | -4.88% | |
| Form 8-K MANGOCEUTICALS, INC. For: Dec 17 | SEC filing · Form 8-K | SEC EDGAR | +0.89% | -31.44% | |
| Form 8-K MANGOCEUTICALS, INC. For: Dec 18 | SEC filing · Form 8-K | SEC EDGAR | +0.89% | -31.44% | |
| Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements | Press release | GlobeNewswire | +1.87% | +18.81% | |
| Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy | Press release | GlobeNewswire | +0.89% | -31.44% | |
| Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules | Press release | GlobeNewswire | +1.24% | +8.26% | |
| Form 8-K MANGOCEUTICALS, INC. For: Dec 04 | SEC filing · Form 8-K | SEC EDGAR | -0.82% | -9.84% | |
| Form 10-Q MANGOCEUTICALS, INC. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -3.31% | -7.35% | |
| Form 10-Q/A MANGOCEUTICALS, INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -3.31% | -7.35% | |
| Form 8-K MANGOCEUTICALS, INC. For: Nov 13 | SEC filing · Form 8-K | SEC EDGAR | +3.54% | +30.97% | |
| Form 8-K MANGOCEUTICALS, INC. For: Nov 13 | SEC filing · Form 8-K | SEC EDGAR | -2.06% | — | |
| Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management | Press release | GlobeNewswire | -2.06% | — | |
| Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs | Press release | GlobeNewswire | +3.54% | +30.97% | |
| Form 8-K MANGOCEUTICALS, INC. For: Sep 15 | SEC filing · Form 8-K | SEC EDGAR | -3.38% | +5.31% | |
| Form 8-K MANGOCEUTICALS, INC. For: Sep 09 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -6.17% | |
| Form 8-K MANGOCEUTICALS, INC. For: Aug 26 | SEC filing · Form 8-K | SEC EDGAR | -0.43% | -5.56% | |
| Form 10-Q MANGOCEUTICALS, INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -2.31% | -5.20% | |
| Form 8-K MANGOCEUTICALS, INC. For: Jul 30 | SEC filing · Form 8-K | SEC EDGAR | +1.21% | +5.42% | |
| Form 8-K MANGOCEUTICALS, INC. For: Jun 10 | SEC filing · Form 8-K | SEC EDGAR | +0.61% | +0.61% | |
| Form 8-K MANGOCEUTICALS, INC. For: Jul 03 | SEC filing · Form 8-K | SEC EDGAR | -3.90% | +7.14% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the MGRX section they belong to.
Where else MGRX is measured.
MGRX earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Mangoceuticals, Inc.'s median reaction calculated?
Every labeled MGRX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 221 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 41% of MGRX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does MGRX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.